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Sllmmary 
In vitro transformation of rabbit peripheral blood mononudear cells (PBMC) with human T 
lymphotropic virus-I (HTLV)-infected human or rabbit cells resulted in CD4-CDS-  cell lines, 
some of which caused acute leukemia when injected into rabbits. Structural analyses of the proviruses 
from cell lines with diverse pathogenic effects provided no clear correlation with lethality. The 
rabbit lines were provisionally designated T  cells because they express interleukin 2R (IL-2R) 
and CD5 and lack surface immunoglobulin, but none express functional T cell receptor (TCR) 
ol or 13 transcripts. A more detailed characterization of the HTLV-I-infected cells was required 
to determine cell lineage and its potential influence on pathogenic consequences. Probes for rabbit 
TCR3r and ~ genes were derived and used to detect 3' and/~ TCR RNA transcripts, identifying 
the in vitro transformed lines as qr//~ T cells. CD4 + and CD8 + lines were derived from PBMC 
of HTLV-I-infected rabbits  and  CD4 +  TCR-~x//3  HTLV-I lines  were derived from rabbit 
thymus,  eliminating  the  possibility  that  the  HTLV-I  isolates  used  here  transform  only 
CD4-CD8-  TCR-3,/# cells. The percentage of 3'//~ cells in rabbit PBMC is relatively  high 
(23% in adult rabbits);  this with diminution of CD4 + and CD8 + cells in IL-2-supplemented 
PBMC or thymocyte cultures may account for selection of rabbit HTLV-I-infected 3///~ T  cell 
lines in vitro. The availability of well-characterized  T  cell lines with diverse in vivo effects in 
the rabbit HTLV-I disease model allows evaluation of roles played by cell type in HTLV-I-mediated 
disease. 
thTOUgh  the majority of individuals infected with human 
lymphotropic virus-I (HTLV-I)  1 remain asymptom- 
atic (1), HTLV-I is the etiological agent for at least two human 
diseases: adult T  cell leukemia/lymphoma (ATL/L) (2, 3) 
and HTLV-I-associated  myelopathy/tropical spastic parapa- 
resis (4). The factors controlling pathogenesis of HTLV-I in- 
fection remain obscure; manifestation of different diseases does 
not correlate with the minor sequence variations among 
different strains of this highly conserved virus (5-7). Like- 
wise, the influence of infected cell type on the outcome of 
infection is not known; most transformed cell lines derived 
from HTLV-I-infected individuals are CD4 + T cells (8, 9), 
although HTLV-I-transformed CD8 + T  cells (10, 11), B 
cells (12-14), and dendritic cells (15) have also been reported. 
Development of relevant animal models for HTLV-I infec- 
tion may provide insight into factors contributing to the varied 
pattern of HTLV-I pathogenesis. 
1 Abbr~tions  used in this  paper: ATL/L, adult T cell leukemia/lymphoma; 
HTLV-I, human T lymphotropic virus-I; Rb, rabbit. 
The rabbit provides an excellent animal model for the study 
of HTLV-I infection. In vivo infection, which may be ac- 
complished by passage of as little as 10/~1 of infected blood, 
leads to seroconversion  and establishment of chronic infec- 
tion (16, 17). Both in vivo and in vitro HTLV-I infections 
lead to cell transformation, allowing derivation of immor- 
talized  rabbit cell lines (17, 18). Although rabbit HTLV-I 
infection usually mimics the healthy asymptomatic condi- 
tions found in most infected humans, a fatal ATL/L-like syn- 
drome was reported under certain experimental conditions 
involving inbred rabbits (19-21).  Our recent studies focus 
on HTLV-I-transformed rabbit cell lines, some of which cause 
disease similar to human ATL/L in outbred rabbits (22). Com- 
parisons of virus sequences from lines that cause fatal disease 
with those that produce asymptomatic infection yielded no 
clear correlation between structure and pathogenic potential 
(23).  This lack of correlation prompted detailed character- 
ization of the HTLV-I-infected cells using newly developed 
reagents (24, 25) in order to determine the influence of cell 
type on HTLV-I pathogenesis. 
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rabbit cell lines, including those causing lethal leukemia, are 
of the  CD4-CD8-  TCK-T/~$  phenotype.  Derivation  of 
HTLV-I-infected CD4 § CD8-  ol/3 T cell lines from rabbit 
thymus and in vivo derivation of CD4-CD8 + and CD4 + 
CD8-  oe/~ T  cell lines indicate that  HTLV-I also infects 
rabbit cell types analogous to those normally obtained from 
HTLV-I-infected humans. The presence of a high percentage 
of "y//~ T  cells in the peripheral blood of adult rabbits and 
selection  by conditions  of cell culture  contribute  toward 
preferential in vitro transformation of 34t$ T cells by HTLV-I. 
The development of reagents and characterization of cell lines 
mark a major refinement of the rabbit HTLV-I model and 
will allow assessment of the roles played by TCR-c~/3 and 
3'/~ T  cells in HTLV-I infection and pathogenesis. 
Materials and Methods 
HTLV-Ilnfection.  All primary cells and tissues used in this study 
were obtained  from New Zealand White rabbits (Hazelton  Re- 
search Products, Inc., Denver, PA) housed at Spring Valley  Labora- 
tories (Woodbine, MD). PBMC were isolated from EDTA-treated 
whole blood by centrifuging  at 750 g for 20 rain. The burly coat 
was removed and the residual red blood calls were lysed with ACK 
lysis buffer (155 #M NH4C1, 10 #m KHCO3, 0.1 ~tM EDTA, pH 
7.4 [B&B/Scott Lab., Fiskville, RI  D. Thymocytes were obtained 
from thymus by mechanical dissociation. Infection of PBMC or 
thymocytes was carried out by coculture  of 5  x  106 cells with 
equal numbers of 3,-irradiated (104 tad) HTLV-I-infected cell lines. 
The human HTLV-I-transformed cell line, MT-2 (26), and the rabbit 
cell line RHT-16 (27), isolated from an infected rabbit, were used 
as sources of  virus. Cells were cultured in media supplemented with 
human IL-2 (RPMI 1640, 10% fetal bovine serum, 100 U/ml recom- 
binant human Ib2 [Bin Source International Inc., Camarillo, CA], 
5 mM t-glutamine, 100 U/ml penicillin, and 50/~g/rni streptomycin) 
in a 37~  humidified incubator  with 5%  CO2.  After "~3 too, 
lines that survived in media lacking 1I.,2 were selected for further 
study. These cell lines are available for research purposes from the 
National Institute of Allergy and Infectious Diseases (NIAID) AIDS 
Research and  Reference Reagent  Program  (Ogden  Bioservices 
Corp.,  Rockville, MD). 
Southern Blot Hybridization.  High molecular weight genomic 
DNA was isolated from the cell lines using an automated nucleic 
acid extractor  (Applied Biosystems, Inc.,  Foster City,  CA) and 
digested with EcoRI (Life Technologies, Inc., Gaithersburg, MD). 
Southern blot analysis was performed as described (28) using a 32p_ 
labeled full-length HTLV-I probe (Oncor Inc., Gaithersburg, MD) 
to reveal the HTLV-I fragments. 
FACS | Analysis.  Cell lines were reacted with several mAbs to 
determine  the composite profile of surface lymphoid  markers. A 
mAb that recognizes rabbit CD4 (Ken-4) (24) was a generous gift 
from Dr. M. Miyasaka (Tokyo Metropolitan  Institute of Medical 
Science, Tokyo, Japan). Anti-rabbit CD8 mAb (12.C7) (29) was 
purchased from Spring Valley  Laboratories. Anti-rabbit DQ (2C4) 
(30) and DR (RDR34) (31) MHC class II molecules, as well as 
the anti-rabbit CD5 (RCD5-4) (25) mAb, were generous gifts from 
Dr.  K. L. Knight.  C3,M1 mAb specific for human  TCR-3, was 
purchased from T Cell Diagnostics, Inc. (Cambridge, MA). FITC- 
conjugated human IL-2 was purchased from R&D Systems, Inc. 
(Minneapolis,  MN).  HTLV-I p19  mAb  was  purchased  from 
Chemicon International, Inc. (Temecula, CA). Cell lines were ana- 
lyzed on a FACScan  |  analyzer (Becton Dickinson  & Co., Moun- 
tain View, CA) using  Consort 30 or Lysys II software. 
Cloning and Sequence Determination of  Rabbit Genes.  Total  cell 
KNA was isolated from normal rabbit PBMC by the RNAzol B 
method (Tel-Test (B), Inc., Friendswood,  TX) and used as a tem- 
plate for synthesis of complementary DNA probes specific  for rabbit 
TCK-v (KbTCK-3,), TCK-8 (KbTCK-~), CD8/~ (KbCD8B), and 
IL-2K~ (RbIDRot). Reported nucleotide sequences of the homol- 
ogous molecules from different species  were aligned using the Mac- 
Vector DNA analysis program  (IBI-A Kodak Co.,  New Haven, 
CT). Conserved regions were identified and degenerate oligonu- 
cleotide primers were synthesized by an oligonucleotide synthesizer 
(Applied Biosystems Inc.) based on these sequences. An exception 
was IL-2Rr*, for which the forward and reverse human  primers 
purchased from Clonetech Laboratory (Palo Alto, CA) were found 
to successfully amplify IL-2Rc~ from rabbit mRNA. First-strand 
cDNA was reverse transcribed from 1 #g of total RNA using the 
oligo  dT  primer  and  subsequently  reverse transcriptase-PCR 
amplified (Perkin Elmer Cetus, Emeryville, CA) using gene-specific 
primers. 
The PCR products  were separated by electrophoresis and the 
appropriate size fragments were excised, purified by Genectean (BIO 
101, Inc.,  Vista, CA),  and  ligated  to the pCRTMII vector (In- 
vitrogen,  San Diego, CA).  Cloned cDNA was sequenced by the 
Sanger method (32) using Sequenase Vet.2 (United States Biochem- 
ical Corp., Cleveland, OH). The gene fragments obtained by this 
technique were identified by alignment of sequences to the analo- 
gous genes from other species and by cell and tissue distribution 
patterns of RNA transcripts hybridizing to them. Percent nucleo- 
tide identity was determined  by MicroGenie  sequence software 
(Beckman Instruments,  Inc.,  Palo Alto,  CA). 
Northern Blot Analyses.  Northern blot analyses were used to 
determine expression patterns of RbCD4, RbCD8B, RbTCR-c~, 
RbTCR-3, RbTCR-3,, RbTCR-/L RbIL-2Rcz, and RbMHC class 
I transcripts by rabbit cell lines, cDNA probes for RbCD4 (33), 
RbTCR-c~ (34), RbTCR-B (35), and RbMHC class I (36) were 
reported previously. Rabbit cDNA probes were radiolabeled with 
[3Zp]dCTP (Amersham Corp., Arlington  Heights,  l'L) by random 
hexamer priming  (37, 38) using T7 Quickprime kit (Pharmacia 
LKB Biotechnology Inc., Piscataway, NJ); hybridization was done 
by established procedures (33). 
Scanning Electron Microscopic  Analyses.  Samples  were prepared 
according to a protocol provided by JFE Enterprise (Brookeville, 
MD). Briefly, washed RI-I/K34, ILHT-16, and RH/Thy-2 lines 
were fixed by 2.5% glutaraldehyde for 2 h, followed by 1 h of os- 
mium tetroxide treatment.  Samples were then dehydrated in a se- 
ries of alcohol washes and critical point dried under pressure. Samples 
were coated with gold-palladium (60% :40%) and subsequently ex- 
amined in a model 1820 scanning electron microscope (Amray Inc., 
Bedford, MA) set at 20 kV. 
Results and Discussion 
In Vitro Derivation of HTLV-l-infected Cell Lines.  HTLV- 
I-transformed cell lines were derived from rabbit PBMC by 
coculture with human or rabbit HTLV-I-infected cell lines. 
The cell lines RH/K30, RH/66A, RH/66E, and RH/66F 
were derived by coculture with irradiated human MT-2 cells 
(26). RH/K34 and RH/K32 were obtained using the in vivo 
transformed  rabbit  cell line RHT-16  (27)  as virus  source. 
Rabbit cell lines require exogenous IL-2 for growth during 
the initial culture stages, but within 3 mo of derivation HTLV- 
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EcoRI sites in HTLV-I,  each  observed  band represents  a copy  of the virus 
flanked  by variable amounts  of rabbit cell  DNA. (/3) Integrated  provirus 
was detected  by digestion of genomic  DNA with EcoRI and Southern 
blot analyses  using a full-length  HTLV-I probe. 
I-transformed lines become IL-2 independent and require no 
further growth factor supplement. All the transformed lines 
are pleomorphic and tend to form cell clumps, whether they 
are adherent or grow in  suspension. 
All derived lines are HTLV-I infected as indicated by var- 
ious criteria. Since there are no internal EcoRI sites within 
the HTLV-I proviral genome, each site of HTLV-I integra- 
tion generates a unique EcoRI restriction fragment that is 
revealed by hybridization with the HTLV-I probe (Fig.  1 A). 
Southern blot analysis of EcoRI-digested DNA showed that 
all cell lines contain integrated HTLV-I provirus (Fig.  1 B). 
The autoradiogram indicates that certain cell lines possess more 
than one HTLV-I copy (or, alternatively, the lines are oligo- 
clonal). RH/K34,  RH/66F,  and RHT-16 have a single in- 
tegrated provirus. No signal was detected with the HTLV-I 
probe in the lane containing EcoRI-digested DNA from the 
Herpesvirus ateles-transformed rabbit cx/B T  cell line, RL-5 
(39).  Nucleotide sequence determination of cloned EcoRI 
fragments containing provirus from RH/K30 and RH/K34 
cell lines revealed that each of these cell lines possesses a full- 
length HTLV-I genome (23).  Reaction of cell lines with a 
fluorescent mAb directed against HTLV-I p19  matrix pro- 
tein revealed the presence of this protein on all lines.  These 
data, along with the ability of the lines to infect other rabbit 
PBMC,  indicate  that  all  are  productively  infected  with 
HTLV-I. 
Surface Markers of HTLV-I Cell Lines.  The transformed 
cell lines were reacted with a panel of mAbs specific for rabbit 
lymphoid cell markers (Table 1) and subjected to FACS  |  anal- 
yses. None of the six PBMC-derived, in vitro transformed 
cell lines express rabbit CD4 or CDS, regardless of the viral 
source used to transform them. Analysis of peripheral blood 
lymphocytes from 20 normal rabbits yielded average values 
of 26.4%  for the CD4 + subpopulation  and 9.5%  for the 
CD8 + subpopulation. This indicates that CD4 + and CD8 + 
cells are present in PBMC as potential targets for HTLV-I 
infection. Exceptions to the double negativity include the 
CD8 + line, RHT-16,  and the CD4 + line, RHT-K29; both 
were derived from PBMC  of HTLV-I-infected rabbits. 
With respect to the other cell surface molecules, all cell 
lines express low to moderate levels of CD5, but none ex- 
press surface Ig. All lines showed binding of  FITC-conjugated 
recombinant human IL-2. This indicates high level expres- 
sion of IL-2R, which is typical of HTLV-I-infected human 
cells (8,  9).  While most lines  express rabbit MHC class II 
antigens to varying degrees, tLH/66A, RH/66E,  and RH/ 
66F, all of  which were derived from the same animal, express 
neither RLA-DQ nor -DR. Even though an average of 23.5% 
of normal rabbit peripheral blood lymphocytes react with 
C'yM1, a mAb directed against human TCR-3,  (40),  none 
of the cell lines reacted. However, the absence of surface TCK-3, 
does not preclude the possibility that the lines are of the ~,//J 
lineage, as HTLV-I infection has been reported to downregulate 
or prevent surface expression of  both the TCR-oe/~ and 'y/~ 
complexes (41,  42). 
Selection of CD4 + Cell Lines.  Because in vitro HTLV-I 
infections consistently resulted in transformation of rabbit 
CD4-CD8-  cells,  the question was raised whether the in 
vitro transformation protocol is capable of producing CD4 + 
HTLV-I transformants. It is known that rabbit CD4 differs 
in  structure from human CD4  (33),  but  this  should not 
influence HTLV-I infectivity as it is unlikely that either CD4 
or CD8 serves as receptor for HTLV-I. Human chromosome 
mapping data localize the HTLV-I receptor to human chro- 
mosome 17 (43), whereas genes for human CD4 and CD8 
are on chromosomes 12 (44) and 2 (45), respectively. To de- 
termine whether rabbit  CD4 +  cells  could be  infected in 
vitro, thymocytes rich in CD4 + and CD8 + cells (Fig.  2 A) 
from two young rabbits were cocnltured with irradiated MT-2 
or RH/66A cells. After I wk, the thymocyte cultures were 
selected for rabbit CD4 + cells by magnetic bead separation 
using anti-rabbit CD4 mAb. This procedure yielded HTLV- 
I-transformed CD4 + cell lines from each thymocyte donor: 
RH/Thy-2  from  the  MT-2  infection  (Fig.  2  B)  and 
RH/Thy66A from infections with RH/66A. Southern blot 
analyses  confirmed that both cell lines harbor HTLV-I provirus. 
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Cell surface markers 
profiled by monoclonal antibodies 
HTLV-I-transformed rabbit 
cell lines  CD4  CD8  CD5  MHC  II  TCK-~ 
Peripheral blood derived 
Viral source: MT-2 
RH/IO0 
RH/66A 
RH/66E 
RH/66F 
RHT-16* 
RH/K29t 
Viral source:  RHT-16 
RH/K32 
RH/K34 
Thymus derived 
Viral source: MT-2 
RH/Thy2 
Viral source:  RH/66A 
RH/Thy66A 
Normal adult rabbit PBMC  (n  =  20) 
_  _  +  + 
--  _  +  _ 
--  --  .4- 
--  +  +  + 
+  --  +  + 
+  + 
+  + 
+  --  +  + 
26.4%  9.5%  ND  ND  23.5% 
(SD  7.4)  (SD 5.8)  (SD 5.8) 
* RHT-16 was derived from PBMC  of a rabbit infected by injection of irradiated  MT-2 cells (27). 
RHT-K29 was derived from PBMC  of a rabbit infected by injection of autologous  PBMC  transformed  by HTLV-I (Sawasdikosol, S.,  unpub- 
lished results). 
An aliquot of the thymocyte culture (not selected by the anti- 
CD4 mAb) was tested for CD4 and CD8 cells 6 mo after 
initiation  of  the  culture  and  shown  to  contain  only 
CD4-CDS-  cells (Fig. 2 C). In a separate experiment,  the 
kinetics of CD4 and CD8 cell depletion was monitored in 
thymocytes cocultured with MT-2 cells;  the percentages of 
CD4 and CD8 cells increased during the first 2 wk of cul- 
ture but then declined to undetectable levels within 3-4 wk 
(data not shown).  Similar reductions of CD4 + and CD8 + 
cells were observed in normal PBMC cultures grown in IL- 
2-supplemented media, even without exposure to the virus. 
The  effect of IL-2 alone on  the  selection of CD4-CDS- 
cells is difficult to assess since normal rabbit lymphocytes do 
not survive in its absence. This selection against CD4 § and 
CD8 + cells in culture provides a plausible explanation  for 
the predominance of double negative cells in HTLV-I infec- 
tion  in vivo. 
The dominance of CD4- CDS-  transformed cells resulting 
from  in  vitro  infection  with  HTLV-I  is  surprising  since 
CD4 +  is  the  predominant  cell  phenotype  derived  from 
HTLV-I-infected human patients (8, 9). However, since other 
infected cell types such  as CD8 + T  cells (10,  11), B  cells 
•TCTRL 
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Figure 2.  FACS  |  analyses  of HTLV-I-transformed thymo- 
cytes during HTLV-I transformation.  (A) Distribution of 
CD4 + and CD8 + cells in a 6-wk-old  rabbit thymus.  (B) 
RH/Thy-2,  CD4 +  HTLV-I-transformed  thymocyte,  was 
magnetic bead selected using anti-rabbit CD4 mAb 1 wk 
after the start of the HTLV-I coculture. No CD8 + cells were 
detected. (C) Total absence of both CD4 and CD8 cells in 
an unselected aliquot of the same thymocyte culture from 
which the CD4 + RH/Thy-2 was rescued, 6 mo after initia- 
tion. Isotype-matched mAb was used as the control (CTRL) 
for primary antibody. 
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HTLV-I patients,  the apparent CD4 selection may reflect 
mechanisms that enable infected CD4 + cells to predominate 
in vivo. It is not dear what other cell types are involved in 
human infection and/or what roles these cell types play in 
the diverse pathology associated with HTLV-I infection. 
Information obtained thus far has not dearly assigned the 
lineage of the CD4-CD8-  cell lines obtained by in vitro 
transformations of rabbit  PBMC.  It  is possible that  the 
CD4-CD8-  cell lines were initially CD4 + or CD8 +, but 
ceased to express these markers with time. This argument 
is weakened by the fact that the rabbit CD4 + and CD8 + 
cell lines have maintained high expression levels of CD4 and 
CD8 over a 1-yr period. Examination of TCR gene expres- 
sion was required to ascertain the lineage of the rabbit HTLV-I 
cell  lines.  Since  the majority of human ~///J T  cells  are 
CD4-CD8-CD5 +, it was postulated that the rabbit cells 
that have a similar surface phenotype are of the 3'//~ lineage. 
To test this possibility,  TCR gene expression patterns were 
determined by Northern blot analyses. 
Probes for Rabbit  TCR-%  TCR-3,  CD8~,  and IL-2Rce. 
Complementary DNA  probes specific for rabbit TCR-% 
TCR-8, CD83, and IL-2Roe were derived to test for the pres- 
ence of TCR transcripts. Degenerate oligonudeotide  primers 
with sequences based on reported homolognes were used to 
amplify fragments from rabbit PBMC RNA. Probes cloned 
in this manner were compared with human and mouse homo- 
logues and percent nudeotide identity for each was deter- 
mined (Table 2). In every case, the rabbit gene is more dosdy 
related to the human than to the mouse homologue. Attempts 
to derive a rabbit CD8oe probe using this approach have been 
unsuccessful and a human CD8ot probe did not hybridize 
with RNA from the cell lines. 
Expression of TCR Genes.  The rabbit gene fragments 
derived here (RbCD8B, RbTCR-% RbTCR-~, and RbIL- 
Table 2.  Derivation  of eDNA Fragments Used as Probes  for Rabbit 
2P,  o  0, along with probes for rabbit CD4 (33), TCR-ot (34), 
TCR-B (35), and dass I MHC genes (36), were used to de- 
termine mRNA expression patterns by the rabbit cell lines 
(Fig. 3).  The CD4-CD8-  status, determined by FACS  | 
analyses, was verified by Northern blots probed with rabbit 
CD4 and CD8B; only the lines sdected from thymus with 
anti-CD4 express the CD4 transcript, and only the in vivo 
transformed RHT-16 cell line expresses CD83 (Fig. 3). The 
absence of both transcripts in other lines was verified by re- 
verse transcriptase-PCR amplification using the CD4 and 
CD83 gene-specific primers; no amplification was detected 
in lines  shown to be negative by Northern blot analysis. 
TCR gene expression was detected by the use of rabbit 
TCR-oe, TCR-/J, TCRqr  and TCR-$ probes (Fig. 3). Anal- 
yses revealed that all CD4-CD8-  cell lines express TCR-3, 
and TCR-/~ transcripts comparable in size to functional human 
transcripts. RNA from the RH/66E, RH/66F, and RHT-16 
cell lines contain bands detected with a RbTCR-oe probe. A 
strong single band corresponding to the functional transcript 
was detected in the RHT-16 RNA sampte, whereas weak 
signals corresponding to both functional and truncated sterile 
transcripts were observed in RH/66E and RH/66F. Hybri- 
dizing sequences were also detected in these three cell lines 
with the RbTCR-B probe. RHT-16 expresses  both functional 
and sterile TCR-3 transcripts; bands corresponding only to 
the TCR-3 sterile transcript are detected in RH/66E and 
RH/66F.  The absence  of a  functional TCR-/3 transcript 
predudes expression of a functional TCR-oe/3 complex in 
RH/66E and RH/66F, despite expression  of a full-length 
TCR<~ transcript. These expression patterns indicate that 
only RHT-16 is capable of forming a functional TCR of the 
oe/3 type and suggest that the other PBMC-derived lines 
express 3'/8 TCR. 
Analysis of Rabbit T Cells by Scanning Electron Microscopy. 
Scanning dectron microscopy further established the similarity 
T Cell Gene Expression 
Forward 
Gene  Reverse 
primers used for amplification 
NT sequence 
Fragment  identity 
length  to prototype 
TCR.-'y  5' CCCAA GCCC/TA CTATG/T TTT/CCT  TCCTT  C Y*  195  82.3%-human* 
5' CCAGC TG/AAAC/T TTCAT GTATG  TG 3'  80.3% -mouse 
TCR-~  5' CCATC T/CGTTT  TT/CG/ATC ATGAA AAATG G 3'  419  80.6%-human 
5' GCAGT CAAGA GAAAA TTGAT/C GGC 3'  77.7%-mouse 
CD8,8  5' GCATC TACTG GCTGA GAGAG CGCCA G 3'  345  80.0%-human 
5' GGCCC TTCTG GGTCT CTGG 3'  62.8%-mouse 
IL-2R~  5' GAATT TATCA TTTCG TGGTG GGGCA 3'  399  77.4%-human 
5' TCTTC TACTC TTCCT CTGTC  TCCG 3'  70.9%-mouse 
* Nudeotide positions  written with slash (/) indicate introduction  of degeneracy  to maximize  identity to reported homologues. 
* These sequence  data are available  from EMBL/GenBank/DDBJ  under accession  numbers: TCR-'y L22290; TCR-$ L22291; CD83 L22293; and 
IL-2R~ L22292. 
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Total cell RNA was isolated from lines derived from PBMC (left lanes) 
or thymus (right lanes) and probed for expression of genes associated with 
lymphocyte function.  Probes for CD8B, TCR-3' and -8, and II~21kc~  are 
described in Table 1. Probes for CD4 (33), TCR-c~ (34), TCR-B (35), 
and class I MHC genes (36) were described previously. 
of rabbit ct//3 and 3'/8 T  cell lines  to human T  cell lines 
and gave further confidence that  the rabbit  CD4-CD8- 
lines are of the 3'/8 type. Examination of three representative 
rabbit lines, RH/K34,  RH/Thy-2,  and RHT-16, revealed 
close correlation in cell morphology to human q,/8 (46) or 
ot/B T  cells (47).  The adherent 3"/8 T  cell line, RH/K34 
(Fig. 4 A), possesses bipolar filopodia, similar to human 3,/8 
T cells, while both the RHT-16 (Fig. 4 B) and RH/Thy-2 
(Fig. 4 C) are similar in morphology to human c~//3 T cells 
(47).  Most RH/K34 cells were ,,o15 #m long; however, it 
was possible to find adherent cells >20 #m in length between 
the widest points of the cytoplasmic extensions. The bipolar 
fusiform is the most common shape in the rabbit 3"/8 cul- 
ture, but large circumscribed discoid cells similar to other 
cultured human 3"/8 T cells were also observed. By contrast, 
the CD4+CD8 -  and CD4-CD8 + o~/~ rabbit T cells were 
monomorphic, 8-12-#m-diam spherical cells similar in mor- 
phology to human (x//3 T  cells (47). 
Role of Infected Cell Type in HTLV-I Disease.  Interest in 
the characterization of these rabbit HTLV-I cell lines is in- 
tensified by the fact that two of them, RH/K34 and RH/K32, 
cause acute leukemia-like disease and death when injected into 
outbred rabbits (22,  23).  Other lines,  including RH/K30 
and RHT-16, given in equal or higher doses, cause infection 
but produce no acute disease. Even though primary struc- 
tural differences exist between the RH/K30 and RH/K34 
viruses, sequence analyses yielded no definitive answer about 
Figure  4.  Scanning electron microscopic analyses of HTLV-l-infected 
rabbit  oe/15 and  "y/8  T  cell  lines. (A)  RH/K34,  an  adherent  rabbit 
CD4-CDS-  2'/8 T  cell, possesses most morphologic characteristics of 
human 2r  T cells (46), including  bipolar fusiform and the presence of 
adherence plaques (insert  x8,000).  (B) RHT-16,  a CD4-CD8 + o~/~ T 
cell.  (C)  KH/Thy-2,  a  CD4+CD8 -  or/15 T  cell. Both  RHT-16  and 
RH/Thy-2 cells are spherical, similar in shape to human ot/B T cell lines 
(47). (A,  x2,600; B and C,  x5,500). 
the role of HTLV-I variation in pathogenesis; not all cell lines 
possessing the HTLV-I sequence found in the lethal lines have 
the ability to cause lethal leukemia (23).  For example,  the 
CD8 + TCR-c~/t3 line, RHT-16, which has an integrated 
viral genome identical in sequence to RH/K34 and RH/K32, 
does not mediate lethal disease. The present data further sug- 
gest that lineage of the infected cell is not the sole factor in 
the development of l~a-like  disease, since both RH/K34, 
which causes lethal disease, and RH/K30, which does not, 
1342  Human T  Lymphocyte Virus-I-infected  Rabbit 3,/8 T  Cell Lines are of the same CD4-CD8-  3~//~ phenotype. Although it 
may be argued that the presence  of a given viral sequence 
in a cell of the appropriate type will provide whatever is neces- 
sary to cause fulminate disease, more extensive data will be 
required to substantiate this. The contribution of other factors, 
such as the immune response to the virus or to virus-infected 
cells, must be explored to determine why only certain HTLV-I 
cell lines  are lethal. 
Reports concerning the effects of HTLV-I infection on 
human "y//$  T cells are beginning to emerge. In vitro suscep- 
tibility of human 3'/# T  cells to HTLV-I infection and the 
subsequent diminution of the cells' cytotoxic effects (42) im- 
plicate HTLV-I "y/~ T cell infection as a potential pathogenic 
factor. Detection of clonal TCK 3~ chain gene rearrangements 
along with monoclonal HTLV-I provirus in cells isolated from 
a skin lesion of an ATL/L patient (48) suggest 3'/~ T  cell 
involvement in skin infiltration characteristic of  ATL/L. Lastly, 
an HTLV-I-infected child with primary immunodeficiency was 
reported to have increased  CD4-CD8-  as well as CD4- 
CD8 + circulating 3'//~ T cells (49).  These data concerning 
the role of "y/fi T  cells in HTLV-I pathology provide an 
impetus for further research.  The rabbit model for HTLV-I 
disease, which is improved substantially by the cell lines and 
reagents developed in this study, can be exploited for studies 
of the puzzling variability seen in HTLV-I pathogenesis. The 
results of these studies will have significant impact on our 
understanding of the varied consequences of human HTLV-I 
infection. 
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